The number of people recovered has reached 46 million

81.3 million Corona cases worldwide

• Police escort small vehicles loaded with the Corona vaccine in Greece.

  A.F.B.

• A woman receives the vaccine in a hospital in Greece.

  A.F.B.

picture

Yesterday, data published by Johns Hopkins University showed that the total number of new cases of the new Corona virus (Covid-19) around the world reached 81.3 cases, as of yesterday, while the total deaths since the outbreak of the epidemic reached one million and 774 thousand cases, and the number of people recovered reached To 46 million, while vaccination campaigns against the virus continued in some European countries, the United States, and separate regions around the world.

Yesterday, the German Robert Koch Institute for Virus Research announced that the number of people who took the first dose of the Corona vaccination reached 41,962 people, indicating that the second dose is expected to be given after about three weeks, so that a complete vaccination can be achieved.

In Britain, a study conducted by the London School of Hygiene and Tropical Medicine concluded that Britain should vaccinate two million people per week, to avoid a third wave of the Corona virus outbreak.

According to the Reuters count, Britain has recorded more than 71 thousand deaths due to the Corona virus, and more than 2.3 million cases of "Covid-19".

The study said: "The only scenario we see to reduce the burden in intensive care units at peak time to below the levels of the first wave is the application of fourth-level rules throughout England, the closure of schools during January, and the vaccination of two million people per week."

In response to this study, the British Ministry of Health said, "The vaccination rate will increase in the coming weeks and months, as millions of doses will become available, and the program will continue to expand."

Yesterday, a prominent epidemiologist warned the British government, asking it to impose stricter general isolation rules to avoid a new wave of deaths due to the new strain of Corona virus.

Andrew Hayward, professor of epidemiology and infectious diseases at University College London, said: "We are entering a new, very dangerous phase of the pandemic, and we will need decisive and early action at the country level, to prevent a catastrophe in January and February."

Hayward, who also chairs a government advisory body specialized in respiratory diseases, confirmed that people are infected with the new strain of the virus easier, which means that the general isolation measures currently imposed in England will likely not be sufficient to slow the spread of the disease.

In addition, clinical trials have begun in the United States and Mexico to determine the efficacy and safety of a vaccine against "Covid-19" produced by the American company "Novavax". Similar experiments are also being conducted on the same vaccine called "NVX-Cove 2373" in Britain. With the participation of 15,000 volunteers.

The experiments in the United States and Mexico will include about 30 thousand volunteers over the age of 18 years, during which two-thirds of the volunteers receive the correct vaccine, and the remaining third will receive a placebo injection, without any of the participants knowing what has been injected.

The American scientist, director of the National Institute of Allergy and Infectious Diseases, Anthony Fauci, said in a statement, “The launch of this study, which is the fifth on a vaccine against (Covid-19), is being subjected to third-phase trials in the United States, demonstrating the determination to eradicate the epidemic by developing Multiple vaccines are safe and effective. ”

The statement added that at least 25% of participants in the trials in the United States and Mexico must be 65 or older.

The focus of the trials will be on recruiting people more vulnerable to "Covid-19", such as African Americans and Hispanics, or people suffering from health problems, such as obesity and diabetes.

The vaccine is taken in two doses, three weeks apart. The Novavax vaccine can be stored at a temperature between two and eight degrees Celsius, that is, in a warmer temperature than the two vaccines of the company, "Pfizer" and "Moderna", which were approved, which means that it can be distributed easily. Larger.

The "Pfizer" and "Moderna" vaccines depend on the new "MRNA" technology, while the "Novavax" vaccine depends on a recombinant protein.

Argentina has become the third country in the world to start vaccinating its citizens against the Corona virus using the Russian "Sputnik V" vaccine outside the framework of experiments, which led to Russia's attempts to push the vaccine it developed to other countries.

And Bloomberg News reported that the vaccination operations began simultaneously in the capital, Buenos Aires, and other provinces at nine o'clock yesterday morning, local time, and it is expected that 300,000 people will receive the vaccine.

Argentina's Health Affairs Regulatory Authority gave emergency approval to use the Russian vaccine last week, after previous approvals it obtained from Russia and Belarus.

• "Novavax" begins clinical trials of its vaccine in the United States, Britain and Mexico.

Follow our latest local and sports news, and the latest political and economic developments via Google news